New report compares within-country variability in provision of surgical procedures in Sweden and 11 OECD countries

14

Apr 2017

Comparison between Swedish counties was made for number of orthopedic, obstetrics and cardiovascular procedures. Data were also compared with 11 OECD countries (Australia, Belgium, Canada, Czech Republic, Finland, France, Germany, Israel, Italy, Portugal, Spain). Data for OECD countries were based on the OECD report “Geographic Variations in Health Care What Do We Know and What Can Be Done to Improve Health System Performance?” Issued in 2014.

Report found that Sweden has high regional variability in provision of cardiovascular procedures (PCI and CABG), but low to moderate variability in provision of orthopedic and obstetrics procedures compared with selected OECD countries.

Key findings of the report:

  • Sweden has second smallest variability in non-surgical admissions (after Belgium)
  • Sweden has one of the largest variability in provision of coronary artery bypass surgery (CABG) (higher variations were detected only in Portugal and Spain)
  • Sweden has one of the largest variability in provision of percutaneous coronary interventions (PCI) (higher variations were detected only in Finland and Spain)
  • Sweden has moderate regional variability for provision of surgery for hip fracture
  • Sweden has one of the lowest regional variability in provision of knee replacement (even lower variations were observed only in Belgium and Czech Republic)
  • Sweden has moderate regional variability for provision of caesarian section
  • Sweden has the lowest regional variability in provision of hysterectomy

Access the report in Swedish here.

The latest related news

23

Mar 2022

In late January 2022, Swedish Medical Technologies Product (MTP) Council issued an updated version of recommendations regarding gene expression analysis for decision-making on the adjuvant breast cancer treatment, initially published in November 2021. The recommendation to the regions remains the same. The changes were only concerned with the clarification of some facts.

Read more

16

Mar 2022

In February 2022, Swedish Medical Technologies Product (MTP) Council issued an updated recommendation on FreeStyle Libre for continuous glucose monitoring in type 2 diabetes (T2D). The initial recommendations were published by NT Council in 2018 and updated by MTP Council in 2020 to include FreeStyle Libre 2. In the 2022 update, MTP Council decreased the Hba1c limit from 70 to 60 mmol/mol and added a statement on lifestyle changes and treatment optimization with non-insulin antidiabetic drugs.

Read more

11

Mar 2022

On February 07, 2022, the Dental and Pharmaceutical Benefits Agency has announced the withdrawal of the assessments of the PhysioMem PM 100 and CardioMem CM 100 XT and the finalization of the assessments of the Zenicor ECG, Coala Heart Monitor Pro, and KardiaMobile. For the conducted assessments, it was outlined that the portable devices provide more limited information than standard ECG measurements; therefore, it was mainly estimated for atrial fibrillation.

Read more

08

Mar 2022

At the end of February 2022, the Dental and Pharmaceutical Benefits Agency (TLV) has launched a theme survey on products for monitoring and diagnostics of sepsis to identify products that may be relevant for health economic assessments at TLV. The suggestions for the products of interest, ongoing clinical studies, or innovation projects could be received until 23 March 2022.

Read more

05

Jan 2022

In December 2021, the Swedish Dental and Pharmaceutical Benefits Agency (TLV) finished the theme survey in the obstructive pulmonary diseases field, which was conducted as a part of the Orderly Introduction for Medical Technologies framework. Identified technologies could potentially be included in the Orderly Introduction of Medical Technologies framework, which aims to facilitate the introduction of novel technologies on the national level.

Read more